PROLEUKIN
NDC 73776-022, aldesleukin, injection, powder, lyophilized, for solution, from Iovance Biotherapeutics, Inc.
- Product NDC
- 73776-022
- Status
- Listed
- Labeler
- Iovance Biotherapeutics, Inc
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA103293
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/73776-022 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ALDESLEUKIN1.1 mg/mL
Pharmacologic classes
Increased Lymphocyte Activation [PE]; Increased Lymphocyte Cell Production [PE]; Interleukin-2 [CS]; Lymphocyte Growth Factor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 73776-022-01 | 73776002201 | 1 VIAL, SINGLE-DOSE in 1 CARTON (73776-022-01) / 1 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/f3c516ad-d405-4fbe-af6a-962080dbfa7d
Use it
Look up 73776-022 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/73776-022 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 73776-022. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.